Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch

about

Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch

Item

http://www.wikidata.org/entity/Q57785830

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Formulation and evaluation of ...... matrix type transdermal patch

@en

Formulation and evaluation of ...... matrix type transdermal patch

@nl

type

Item

label

Formulation and evaluation of ...... matrix type transdermal patch

@en

Formulation and evaluation of ...... matrix type transdermal patch

@nl

prefLabel

Formulation and evaluation of ...... matrix type transdermal patch

@en

Formulation and evaluation of ...... matrix type transdermal patch

@nl

P1476

Formulation and evaluation of ...... matrix type transdermal patch

@en

P2093

Ajay K Banga

http://www.w3.org/2001/XMLSchema#string

Bruce E Blough

http://www.w3.org/2001/XMLSchema#string

Kevin S Murnane

http://www.w3.org/2001/XMLSchema#string

Sindhu S Ganti

http://www.w3.org/2001/XMLSchema#string

Sonalika A Bhattaccharjee

http://www.w3.org/2001/XMLSchema#string

P2860

Agonist Medications for the Treatment of Cocaine Use Disorder

Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration

Pressure-sensitive adhesives for transdermal drug delivery systems.

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Drug addiction: the neurobiology of behaviour gone awry.

Medication development for addictive disorders: the state of the science.

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies.

Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.

Treatment strategies for co-occurring ADHD and substance use disorders

P304

71-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJPHARM.2018.08.033

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

550

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30125654

http://www.w3.org/2001/XMLSchema#string

P932

6195313

http://www.w3.org/2001/XMLSchema#string